26 February 2019 | News
FIND expertise will help CARB-X ensure diagnostic investments have maximum impact globally against antimicrobial resistance (AMR)
Image credit- roche.com
The Foundation for Innovative New Diagnostics (FIND) and the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) have announced that FIND is joining the CARB-X Global Accelerator Network.
The CARB-X Global Accelerator Network now includes 10 organizations, providing business, scientific, and technical expertise and services to CARB-X-funded companies to support their antibacterial research projects.
FIND will play a leading role in supporting CARB-X diagnostic investments around the world, and in supporting new applicants for CARB-X funding for the development of diagnostics.
FIND will also be positioned to help companies assess how diagnostic solutions could be used in resource-poor settings. Joining the network enhances FIND’s unique view of the global antimicrobial resistance (AMR) diagnostics pipeline, allowing FIND’s own diagnostic development investments to be strategically aligned with global unmet needs.